Cambridge BioMarketing Campaign Raises Awareness for Rare Disease Research

#SupportTheSearch campaign donates proceeds of social media initiative to three rare disease groups in honor of Rare Disease Day 2017

Cambridge BioMarketing's "rare" train car along the Massachusetts Bay Transportation Authority (MBTA) Red Line. (Photo: Business Wire)

CAMBRIDGE, Mass.--()--Cambridge BioMarketing, the world’s leading rare disease and specialty communications agency, announced its #SupportTheSearch social media campaign to raise awareness for rare diseases and the need for research to find cures. As part of the campaign, the agency is wrapping the inside and outside of a train car on the Massachusetts Bay Transportation Authority (MBTA) Red Line with facts about rare diseases and zebra stripe branding. The significance of this branding is that a “zebra” is medical slang for a rare diagnosis. The campaign will run until March 6, 2017.

For every #SupportTheSearch social media post during the month-long campaign, Cambridge BioMarketing will make a donation to Global Genes, NORD and the Rare Disease United Foundation to help to raise funds for rare disease research. On Feb. 28, 2017, countries around the world will celebrate the 10th annual Rare Disease Day to raise awareness about rare diseases and their impact on patients’ lives. This year’s theme is research, which can lead to the identification and understanding of unknown diseases, enabling doctors to provide correct diagnoses that can lead to new cures and treatments. Today, there are approximately 7,000 different types of rare diseases and disorders, and 30 million people in the United States are living with rare diseases.

“We pride ourselves in not only connecting patients with transformational, potentially life-saving medicines, but also being advocates for the rare disease community,” said Maureen Franco, CEO, Cambridge BioMarketing. “Research is a powerful tool these great organizations have to provide hope and change for people living with rare diseases and their families and we are committed to amplifying their voices.”

In addition to #SupportTheSearch, CB will also be co-hosting a tweetchat with MassBio on Feb. 15 from 7-8 p.m., EST discussing the challenges associated with rare disease research. Those interested in the tweetchat can use #PatientDriven to follow along and submit questions. Cambridge BioMarketing will also make its film, “Rare in Common,” available for public download on Rare Disease Day. The film debuted as a private screening on Rare Disease Day 2016 to honor people living with the challenges of a rare disease and to give their amazing stories an opportunity to be heard.

#SupportTheSearch Details:

     

WHO:

Cambridge BioMarketing
 

WHAT:

#SupportTheSearch Campaign
 

WHEN:

The campaign will run until March 6, 2017
 

Campaign Details: Share a picture or inspirational message on Twitter, Facebook or Instagram using #SupportTheSearch. For each post, Cambridge BioMarketing will make a donation to one of the three rare disease organizations below.

Benefactors: NORD, Global Genes and Rare Disease United Foundation

Handles:

  • Twitter: @cambridgebmg
  • Instagram: @cambridgebiomarketing
  • Facebook: Cambridge BioMarketing

About Cambridge BioMarketing
Cambridge BioMarketing is a rare disease and specialty communications agency, blending medical insights and award-winning creativity with deep experience to build some of the world’s most successful brands. With solutions for our clients that empower, educate, and activate, we bring physicians, specialists, and patient communities together to transform human health in the face of devastating, under-appreciated disease states. Founded in 2001, Cambridge BioMarketing has offices in Cambridge, MA and Oakland CA, and is a division of Everyday Health, Inc. For more information, visit: www.cambridgebmg.com.

Contacts

PAN Communications for Cambridge BioMarketing
Kathryn McMahon, 617-502-4300
cbm@pancomm.com

Contacts

PAN Communications for Cambridge BioMarketing
Kathryn McMahon, 617-502-4300
cbm@pancomm.com